Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment Journal Article


Authors: Pratt, T. S.; Pincus, S. H.; Hale, M. L.; Moreira, A. L.; Roy, C. J.; Tchou-Wong, K. M.
Article Title: Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment
Abstract: To investigate the effectiveness of passive antibody treatment as post-exposure therapy for ricin, we had developed an oropharyngeal aspiration model for ricin lethal challenge and antibody administration. When polyclonal anti-deglycosylated ricin A-chain antibody (dgA Ab) was administered between 1-18 hr after ricin challenge, all animals survived while delayed treatment to 24 hr resulted in 30% survival. The protective effects of dgA Ab correlated with inhibition of apoptosis in the lungs in vivo and in RAW264.7 macrophage and Jurkat T cells in vitro. In addition, ricin-induced cell cytotoxicity was inhibited by both dgA Ab and RAC18 monoclonal antibody against ricin A-chain. Administration of RAC18 monoclonal antibody at 4, 18, and 24 hr after ricin exposure resulted in 100%, 60% and 50% protection, respectively, suggesting that the therapeutic window for passive vaccination extended to at least 24 hr post-ricin lung challenge. Copyright © Informa Healthcare USA, Inc.
Keywords: survival; controlled study; human cell; nonhuman; animal cell; mouse; animals; mice; cell survival; apoptosis; lung toxicity; aspiration; cell line; inflammation; in vivo study; cytotoxicity; mice, inbred balb c; antibodies, monoclonal; evaluation; lung; antibodies; cell protection; lethality; oropharynx; experimental model; passive immunization; provocation test; lung aspiration; ricin; passive antibody; post-exposure treatment; ricin a; ricin antibody; pulmonary edema
Journal Title: Experimental Lung Research
Volume: 33
Issue: 8-9
ISSN: 0190-2148
Publisher: Informa Healthcare  
Date Published: 2007-10-01
Start Page: 459
End Page: 481
Language: English
DOI: 10.1080/01902140701731805
PUBMED: 17994372
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 8" - "Export Date: 17 November 2011" - "CODEN: EXLRD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andre L Moreira
    176 Moreira